These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7104185)

  • 1. Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient.
    Porro MG; Kupferberg HJ; Porter RJ; Theodore WH; Newmark ME
    Br J Clin Pharmacol; 1982 Aug; 14(2):294-7. PubMed ID: 7104185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of phenytoin on phenobarbitone and primidone metabolism.
    Lambie DG; Johnson RH
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):148-51. PubMed ID: 7217971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylethylmalonamide serum levels in patients treated with primidone and the effects of other antiepileptic drugs.
    Streete JM; Berry DJ; Pettit LI; Newbery JE
    Ther Drug Monit; 1986; 8(2):161-5. PubMed ID: 3088778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of phenytoin and ethosuximide on primidone metabolism in patients with epilepsy.
    Schmidt D
    J Neurol; 1975 Jun; 209(2):115-23. PubMed ID: 51048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of primidone in elderly patients.
    Martines C; Gatti G; Sasso E; Calzetti S; Perucca E
    Br J Clin Pharmacol; 1990 Oct; 30(4):607-11. PubMed ID: 2291873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.
    Nau H; Rating D; Häuser I; Jäger E; Koch S; Helge H
    Eur J Clin Pharmacol; 1980 Jul; 18(1):31-42. PubMed ID: 7398746
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium.
    Battino D; Binelli S; Bossi L; Como ML; Croci D; Cusi C; Avanzini G
    Clin Pharmacokinet; 1984; 9(3):252-60. PubMed ID: 6734014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose kinetics of primidone in human subjects: effect of phenytoin on formation and elimination of active metabolites of primidone, phenobarbital and phenylethylmalonamide.
    Sato J; Sekizawa Y; Yoshida A; Owada E; Sakuta N; Yoshihara M; Goto T; Kobayashi Y; Ito K
    J Pharmacobiodyn; 1992 Sep; 15(9):467-72. PubMed ID: 1287181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of primidone, phenylethylmalonamide, and phenobarbital in the rabbit.
    Hunt RJ; Miller KW
    Drug Metab Dispos; 1978; 6(1):75-81. PubMed ID: 23277
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions between primidone, carbamazepine, and nicotinamide.
    Bourgeois BF; Dodson WE; Ferrendelli JA
    Neurology; 1982 Oct; 32(10):1122-26. PubMed ID: 6214728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary metabolites of phenobarbitone, primidone, and their N-methyl and N-ethyl derivatives in humans.
    Treston AM; Hooper WD
    Xenobiotica; 1992 Apr; 22(4):385-94. PubMed ID: 1523859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Br J Clin Pharmacol; 1977 Oct; 4(5):541-7. PubMed ID: 911604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of encapsulation of primidone on its oxidative metabolism in rats.
    Ferranti V; Chabenat C; Marchais H; Ménager S; Hue H; Orecchioni AM; Lafont O
    Drug Metabol Drug Interact; 2001; 18(3-4):191-208. PubMed ID: 11791884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of phenytoin and primidone.
    Reynolds EH; Fenton G; Fenwick P; Johnson AL; Laundy M
    Br Med J; 1975 Jun; 2(5971):594-5. PubMed ID: 1131627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid as an inhibitor of primidone metabolism.
    Sutton G; Kupferberg HJ
    Neurology; 1975 Dec; 25(12):1179-81. PubMed ID: 812007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs.
    Cottrell PR; Streete JM; Berry DJ; Schäfer H; Pisani F; Perucca E; Richens A
    Epilepsia; 1982 Jun; 23(3):307-13. PubMed ID: 7084140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of primidone metabolism and excretion in children.
    Kauffman RE; Habersang R; Lansky L
    Clin Pharmacol Ther; 1977 Aug; 22(2):200-5. PubMed ID: 884921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.
    Callaghan N; Feely M; Duggan F; O'Callaghan M; Seldrup J
    Acta Neurol Scand; 1977 Jul; 56(1):1-6. PubMed ID: 878841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the intracerebral metabolism of anticonvulsant drugs--I. Perfusion of primidone through the isolated brain of the rat.
    Höller M; Penin H
    Biochem Pharmacol; 1984 Jun; 33(11):1753-6. PubMed ID: 6732842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients.
    Houghton GW; Richens A; Toseland PA; Davidson S; Falconer
    Eur J Clin Pharmacol; 1975 Oct; 9(1):73-8. PubMed ID: 1233256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.